Research Article
Clinical Usefulness of Bioavailable Vitamin D and Impact of GC Genotyping on the Determination of Bioavailable Vitamin D in a Korean Population
Table 5
Major GC genotype and allele frequencies.
| | Healthy controls () | Patients with LC () | valuea | Pregnant women () | valueb | Total () |
| | Genotype frequencies | | Gc1f/Gc1f | 9 (17.0%) | 7 (15.6%) | 0.849 | 4 (10.5%) | 0.386 | 20 (14.7%) | | Gc1f/Gc1s | 13 (24.5%) | 4 (8.9%) | 0.042 | 8 (21.1%) | 0.698 | 25 (18.4%) | | Gc1f/Gc2 | 18 (34.0%) | 13 (28.9%) | 0.590 | 18 (47.4%) | 0.197 | 49 (36.0%) | | Gc1s/Gc1s | 3 (5.7%) | 2 (4.4%) | 1.000 | 2 (5.3%) | 1.000 | 7 (5.1%) | | Gc1s/Gc2 | 5 (9.4%) | 14 (31.1%) | 0.007 | 4 (10.5%) | 1.000 | 23 (16.9%) | | Gc2/Gc2 | 5 (9.4%) | 5 (11.1%) | 1.000 | 2 (5.3%) | 0.695 | 12 (8.8%) | | Allele frequencies | | Gc1f | 49 (46.2%) | 31 (34.4%) | 0.094 | 34 (44.7%) | 0.842 | 114 (41.9%) | | Gc1s | 24 (22.6%) | 22 (24.4%) | 0.767 | 16 (21.1%) | 0.799 | 62 (22.8%) | | Gc2 | 33 (31.1%) | 37 (41.1%) | 0.146 | 26 (34.2%) | 0.662 | 96 (35.3%) |
|
|
In apatients with LC and bpregnant women, genotype and allele frequencies were compared with the healthy controls. LC: liver cirrhosis.
|
